We just covered the 7 Best Lab-Grown Meat Stocks to Invest In and Pluri Inc. (NASDAQ:PLUR) ranks 4th on this list.
Pluri Inc. (NASDAQ:PLUR), through the highly publicized joint venture, Ever After Foods, utilizes proprietary, state-of-the-art 3D bioreactor systems to cultivate animal cells with unprecedented density and cost efficiency
While most cell-cultured companies struggle with the cost of scaling beyond small pilot batches, Pluri’s industrial platform delivers up to a 700% increase in cell production volume compared to conventional methods. This highly specialized technology enables the creation of complex, structured tissues using significantly less expensive growth media. This operational advantage solves the primary hurdle that has long prevented cultured meat from achieving price parity with traditional livestock, transforming Pluri into an essential manufacturing backbone for the global cellular sector.
Jaroslav Francisko/ In the latest earnings report, Pluri Inc. (NASDAQ:PLUR) posted losses per share of $0.55, outperforming Wall Street consensus analyst expectations of losses per share of 0.66 by 16.67%. This marks an operational improvement compared to the losses per share of $0.94 reported in the same prior-year quarter. The firm’s multi-pronged commercial strategy spans highly lucrative sectors outside of food technology, including clinical-grade contract development and manufacturing organization services and high-margin cell therapies.